Results of a phase I trial with MART-1 T cell receptor modified T cells in patients with metastatic melanomaM.W. Rohaan,R. Gomez-Eerland,M H Geukes Foppen,M. van Zon,R. de Boer,N.A.M. Bakker,L.M. Pronk,A. Sari,H.A. Mallo,B.A. van de Wiel,F. Lalezari,J.H. Beijnen,B. Nuijen,H. van Tinteren,J.V. van Thienen,C.U. Blank,S. Wilgenhof,T.N. Schumacher,J.H. van den Berg,J B A G HaanenAnnals of Oncology（2019）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
